Literature DB >> 2419335

Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.

O Takikawa, R Yoshida, R Kido, O Hayaishi.   

Abstract

Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase was characterized, taking advantage of its induction by bacterial lipopolysaccharide. Our results demonstrated that in various tissues, N-formylkynurenine produced by the dioxygenase from tryptophan was rapidly hydrolyzed into kynurenine by a kynurenine formamidase, but it was not further metabolized. The localization in the liver and kidney of the kynurenine-metabolizing enzymes suggested that kynurenine thus formed was transported by the bloodstream to those two organs to be metabolized. In fact, the plasma kynurenine level increased in parallel with the induction of the dioxygenase by lipopolysaccharide, and kinetic analysis indicated that at the maximal induction of the enzyme there was a 3-fold increase in the kynurenine production. The major metabolic route of kynurenine was excretion in urine as xanthurenic acid. This increase in the kynurenine production was not explained by L-tryptophan 2,3-dioxygenase in the liver, because during the induction of indoleamine 2,3-dioxygenase, the hepatic enzyme level was substantially suppressed. These findings indicated that indoleamine 2,3-dioxygenase actively oxidized tryptophan in mice and that its induction resulted in an increase in tryptophan degradation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419335

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.

Authors:  Paul B Larkin; Korrapati V Sathyasaikumar; Francesca M Notarangelo; Hiroshi Funakoshi; Toshikazu Nakamura; Robert Schwarcz; Paul J Muchowski
Journal:  Biochim Biophys Acta       Date:  2016-07-05

2.  Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in mouse.

Authors:  Manuela Schmid; Maik J Lehmann; Richard Lucius; Nishith Gupta
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

Review 3.  Revisiting the host as a growth medium.

Authors:  Stacie A Brown; Kelli L Palmer; Marvin Whiteley
Journal:  Nat Rev Microbiol       Date:  2008-09       Impact factor: 60.633

Review 4.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

5.  Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.

Authors:  Chenggang Yang; Yongchun Zhou; Lijuan Zhang; Congguo Jin; Mei Li; Lijuan Ye
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 6.  [Immunology in schizophrenic disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

7.  Kynurenine, a Tryptophan Metabolite That Accumulates With Age, Induces Bone Loss.

Authors:  Mona El Refaey; Meghan E McGee-Lawrence; Sadanand Fulzele; Eileen J Kennedy; Wendy B Bollag; Mohammed Elsalanty; Qing Zhong; Ke-Hong Ding; Nathaniel G Bendzunas; Xing-Ming Shi; Jianrui Xu; William D Hill; Maribeth H Johnson; Monte Hunter; Jessica L Pierce; Kanglun Yu; Mark W Hamrick; Carlos M Isales
Journal:  J Bone Miner Res       Date:  2017-08-14       Impact factor: 6.741

8.  Attenuation of antigenic immunogenicity by kynurenine, a novel suppressive adjuvant.

Authors:  Zhiqing Duan; Yunqing Duan; Huangui Lei; Ningzhu Hu; Jiandong Shi; Dong Shen; Xi Wang; Yunzhang Hu
Journal:  Hum Vaccin Immunother       Date:  2014-02-28       Impact factor: 3.452

9.  Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology.

Authors:  Mohamad El-Zaatari; Yu-Ming Chang; Min Zhang; Matthew Franz; Andrew Shreiner; Andrew J McDermott; Koenraad F van der Sluijs; René Lutter; Helmut Grasberger; Nobuhiko Kamada; Vincent B Young; Gary B Huffnagle; John Y Kao
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

10.  A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.

Authors:  Lisa I Greene; Tullia C Bruno; Jessica L Christenson; Angelo D'Alessandro; Rachel Culp-Hill; Kathleen Torkko; Virginia F Borges; Jill E Slansky; Jennifer K Richer
Journal:  Mol Cancer Res       Date:  2018-08-24       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.